World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page

T-Cell Therapy in Solid Tumors May Be Improved by Enzyme

by admin | Mar 28, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

T-Cell Therapy in Solid Tumors May Be Improved by Enzyme

By Genetic Engineering and Biotechnology News –

T cells are not able to create their cellular energy, called adenosine triphosphate or ATP, when they are inside a solid tumor. Now, researchers led by UNC Lineberger Comprehensive Cancer Center may have discovered the culprit behind T cells’ loss of energy. The new findings could be used to make multiple types of T-cell therapies more effective for patients.

Their findings are published in Cell Metabolism in an article titled, “Acetyl-CoA carboxylase obstructs CD8+ T cell lipid utilization in the tumor microenvironment.”

Click here to read the full article

More Posts from News Feed

  • Signs of Alzheimer’s were everywhere. Then his brain improved
    Signs of Alzheimer’s were everywhere. Then his brain…
  • Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors
    Novel CAR T-cell therapy demonstrates efficacy and…
  • Tiny Test Tubes Sort Stem Cells for Improved Therapy
    Tiny Test Tubes Sort Stem Cells for Improved Therapy

Recent Posts

  • Infant becomes world’s first patient to undergo personalized gene-editing treatment
  • Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
  • Embryonic macrophages found to control blood stem cell numbers in bone marrow
  • Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
  • The stem cell race for Parkinson’s disease: Recent studies show significant promise
  • New Cell Therapy For Resistant Hodgkins Patients
World Stem Cell Summit Logo - White version
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow